Email [email protected] Mentor Michel Sadelain, MD, PhD Start Year 2015 Education BS, University of Toronto; MS, Swiss Federal Institute of Technology Zurich Fellowships Geoffrey Beene Graduate Student Fellowship (2016-2017) Canadian Institutes of Health Research Doctoral Research Award 2017-2020 Publications Hamieh M, Dobrin A, Cabriolu A, van der Stegen SJC, Giavridis T, Mansilla-Soto J, Eyquem J, Zhao Z, Whitlock BM, Miele MM, Li Z, Cunanan KM, Huse M, Hendrickson RC, Wang X, Rivière I, Sadelain M. (2019) CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature. 568, 112-116. Feucht J, Sun J, Eyquem J, Ho YJ, Zhao Z, Leibold J, Dobrin A, Cabriolu A, Hamieh M, Sadelain M. (2018) Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat Med. [Epub ahead of print]. Dobrin A, Saxena P, Fussenegger M. (2015) Synthetic biology: applying biological circuits beyond novel therapies. Integr Biol (Camb), 8, 409-430. [Epub ahead of print]. Łuksza M, Sethna ZM, Rojas LA, Lihm J, Bravi B, Elhanati Y, Soares K, Amisaki M, Dobrin A, Hoyos D, Guasp P, Zebboudj A, Yu R, Chandra AK, Waters T, Odgerel Z, Leung J, Kappagantula R, Makohon-Moore A, Johns A, Gill A, Gigoux M, Wolchok J, Merghoub T, Sadelain M, Patterson E, Monasson R, Mora T, Walczak AM, Cocco S, Iacobuzio-Donahue C, Greenbaum BD, Balachandran VP. (2022) Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Nature. Online ahead of print.